NCT05713253 is a NA clinical trial of ELITA System in Refractive Error, sponsored by Johnson & Johnson Surgical Vision, Inc..

Who is sponsoring NCT05713253?

NCT05713253 is sponsored by Johnson & Johnson Surgical Vision, Inc..

What drugs are being tested in NCT05713253?

Interventions in NCT05713253: ELITA System.

What condition does NCT05713253 study?

NCT05713253 studies Refractive Error.

Is NCT05713253 still recruiting?

NCT05713253 is currently terminated. Last updated 16 March 2026.

Last reviewed 2026-03-16 · How we verify

NCT05713253

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM

Terminated NA Last updated 16 March 2026

What this trial tests

NA trial testing ELITA System in Refractive Error in 96 participants. Terminated before completion.

Timeline

2 February 2023

Primary endpoint
21 February 2025

21 February 2025

Quick facts

Lead sponsor	Johnson & Johnson Surgical Vision, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	96
Start date	2 February 2023
Primary completion	21 February 2025
Estimated completion	21 February 2025
Sites	2 locations across United States

Drugs / interventions tested

ELITA System

Conditions studied

Refractive Error — all drugs for Refractive Error →

Sponsor

Johnson & Johnson Surgical Vision, Inc. — full company profile →

Who can join

22 and older, any sex, with Refractive Error. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a 2-phase, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation to confirm the safety and effectiveness of the ELITA system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Refractive Error

Currently open trials in the same condition.

NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting

Other Johnson & Johnson Surgical Vision, Inc. trials

Trials by the same sponsor.

NCT07324200 — Objective Assessment of Intraocular Lens Tilt and Decentration · recruiting
NCT07218419 — Comparison of Methods for Assessing Intraocular Lens Position · completed
NCT06797856 — Measurement of Refractive Error in Pseudophakic Eyes Using an Autorefractor and a Wavefront Aberrometer · completed
NCT05090787 — Clinical Investigation of the TECNIS 1-Piece Intraocular Lens · NA · withdrawn
NCT06767319 — Prospective, Multi-center, Non-interventional, Open Label, Randomized (Depth of Focus Testing Sequences), Clinical Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05713253 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Surgical Vision, Inc.
Last refreshed: 16 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing